Nonprofit · EIN 46-1274306
A CURE IN SIGHT
Tax-exempt · RALEIGH, NC 27658
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2025 | 990 | $524,907 | $565,711 | -$40,804 | $64,431 | $0 | $64,431 |
| December 31, 2024 | 990 | $475,746 | $551,440 | -$75,694 | $114,785 | $9,550 | $105,235 |
| December 31, 2023 | 990 | $408,550 | $491,328 | -$82,778 | $197,429 | $0 | $197,429 |
Financial details: 990 for the year ended December 31, 2025
Revenue
- Contributions, gifts and grants
- $345,658
- Program service revenue
- $106,000
- Investment income
- $0
- Net income from fundraising events
- $73,224
- Net income from sales of inventory
- $25
- Other revenue
- $73,249
Expenses
- Grants and similar amounts paid
- $44,752
- Compensation of officers, directors and key employees
- $59,449
- Other salaries and wages
- $2,017
- Salaries, compensation and benefits (total)
- $69,222
- Professional fundraising fees
- $0
- Legal fees
- $31,774
- Accounting fees
- $24,452
- Occupancy
- $18,240
- Travel
- $33,003
- Program services (functional)
- $96,017
- Management and general (functional)
- $413,514
- Fundraising (functional)
- $11,428
Balance sheet and other
- Total assets, start of year
- $105,235
- Total assets, end of year
- $64,431
- Total liabilities, end of year
- $0
- Net assets, end of year
- $64,431
- Net assets without donor restrictions
- $64,431
- Gross unrelated business income
- $73,224
- Gross receipts
- $650,861
- Employees
- 0
- Volunteers
- 4
- Year formed
- 2014
- State of legal domicile
- NC
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Melody King | President Officer | 10 | $0 |
| Marlene Day | Treasurer Officer | 5 | $0 |
| Loren Seaman | Vice President Officer | 5 | $0 |
| Chris Brotherstom | Board Member Officer | 5 | $0 |
990 for the year ended December 31, 2024: 4 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Melody King | President Officer | 10 | $0 |
| Suzanne Luscure | Secretary Officer | 5 | $0 |
| Marlene Day | Treasurer Officer | 5 | $0 |
| Loren Seaman | Vice President Officer | 5 | $0 |
990 for the year ended December 31, 2023: 4 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Melody King | President Officer | 10 | $0 |
| Suzanne Luscure | Secretary Officer | 5 | $0 |
| Marlene Day | Treasurer Officer | 5 | $0 |
| Loren Seaman | Vice President Officer | 5 | $0 |
Address and contacts
- Address (IRS master file)
- PO BOX 58113, RALEIGH, NC 27658-8113
- In care of
- % MELODY KING
- Mailing address (990-N for 2013)
- 40 Cornerstone DR, Franklinton NC 27525
- Principal officer (990 for 2025)
- Melody Burchett, PO Box 58113, Raleigh, NC 27658
- Principal officer (990-N for 2013)
- Melody Kling, 40 Cornerstone Dr, Franklinton NC 27525
- Signed the 990
- Christian Davis, Accountant
- Phone
- (919) 885-5264
- Website
- acureinsight.net
Mission
A Cure in Sight ACIS supports families who have ocular melanoma and focuses on research for a cure. Through public and private partnerships we provide clear and reliable education information providing a support community to patients and their caregivers. ACIS educates the public about ocular melanoma treatment options clinical trials that may improve their prognosis making it less overwhelming. ACIS is dedicated to ongoing research. We know we can accelerate viable research projects that otherwise would stall and not be completed missing opportunities to advance research for effective treatments and possibly a cure.
Program accomplishments
- Provides education on ocular melanoma to help patients understand their cancer better.Expenses $96,017
- Financially supports patients with living expenses and travel for treatmentrevenue $6,124
- Supporting research projects for a cure for ocular melanoma0
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | 990 on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 46-1274306
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2014
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H12)
- Assets (IRS master file)
- $64,431
- Income (IRS master file)
- $650,861
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2025 | $524,907 | $565,711 | $64,431 | XML |
| 990 | December 2024 | $475,746 | $551,440 | $114,785 | IRS |
| 990 | December 2023 | $408,550 | $491,328 | $197,429 | XML |
| 990 | December 2022 | $641,566 | $451,572 | $280,207 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
| 990-N for 2013 Officer: Melody Kling | December 31, 2013 | ≤ $50,000 receipts | – | – | e-Postcard |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 46-1274306).
Questions about A CURE IN SIGHT
- What is the EIN of A CURE IN SIGHT?
- The employer identification number (EIN) of A CURE IN SIGHT is 46-1274306.
- Is A CURE IN SIGHT tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2014.
- Are donations to A CURE IN SIGHT tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does A CURE IN SIGHT file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of A CURE IN SIGHT due?
- The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did A CURE IN SIGHT last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2025.
- Who is the principal officer of A CURE IN SIGHT?
- The 990 for the year ended December 31, 2025 names Melody Burchett.
- Who are the officers and directors of A CURE IN SIGHT?
- The 990 for the year ended December 31, 2025 lists 4 people; 0 received compensation from the organization.
- How much revenue does A CURE IN SIGHT have?
- On its 990 for the year ended December 31, 2025 it reported revenue of $524,907, expenses of $565,711 and total assets of $64,431 at year end.
Other nonprofits in RALEIGH
- ROME FOUNDATION EIN 54-1808958 · last filed 990 for 2025
- LEROY ALLEN FOUNDATION EIN 33-2274759 · last filed 990-PF for 2025
- HEALTH RESEARCH ALLIANCE INC EIN 68-0617198 · last filed 990 for 2025
- NORTH CAROLINA PEDIATRIC SOCIETY INC EIN 31-1657902 · last filed 990 for 2025
- HEALTH ENHANCEMENT RESEARCH ORGANIZATION INC EIN 63-1141480 · last filed 990 for 2024
- NORTH CAROLINA ASSOCIATION FOR BIOMEDICAL RESEARCH EIN 56-1683704 · last filed 990 for 2025
- NEUROIMMUNE NORTH CAROLINA EIN 92-2877475 · last filed 990 for 2026
- CANCER BIOLOGY TRAINING CONSORTIUM EIN 26-0497269 · last filed 990 for 2025
All nonprofits in RALEIGH · North Carolina · Medical research